BIRMEVAX
Covid-19, protein subunit
Product Details
WHO Product ID
FVP-P-453
Status
Prequalified
Date of prequalification
Vaccine type
Covid-19, protein subunit
Abbreviated Name
C-19
Commercial Name
BIRMEVAX
PQ Holder
HIPRA HUMAN HEALTH, S.L.U
Avda. la Selva. 135
Amer,
Girona
17170
Spain
Responsible NRA
European Medicines Agency
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
1
Multidose Vial Policy
Not applicable
Shelf life (months)
15 months
Storage temperature
2 - 8°C
Diluent
N/A
Preservative
None
Product Packaging
Secondary Container
Tertiary Container
Component Packed
Active (Vaccine)
Total doses
20
Description
Carton box of 20 vials
Dimensions
9.2 x 10.5 x 4.6 cm
Cold Chain Volume (cm³/dose)
22.22
Component Packed
Active (Vaccine)
Total doses
5
Description
Carton box of 5 vials
Dimensions
9.2 x 10.5 x 4.6 cm
Cold Chain Volume (cm³/dose)
88.87
Component Packed
Active (Vaccine)
Total doses
10
Description
Carton box of 10 vials
Dimensions
9.2 x 10.5 x 4.6 cm
Cold Chain Volume (cm³/dose)
44.44
